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 Circadian Blood Pressure Proﬁ le in Patients with Active 
Cushing ’ s Disease and after Long-term Cure 
levels and their variability  [10 – 12] . Blood pres-
sure variability is a complex phenomenon which 
includes short lasting changes induced by emo-
tion and exercise as well as more prolonged ﬂ uc-
tuations, such as those between wakefulness and 
sleep  [13] . Blood pressure usually falls by 20 – 25  % 
of daytime values during the night, the so-called 
 “ dipping ” phenomenon, and this pattern is pre-
served in the majority of hypertensive patients. 
Approximately one third of hypertensives, how-
ever, fail to present a nocturnal blood pressure 
decrease, leading to the separation of patients 
into  “ dippers ” and  “ nondippers ”  [11,  14] . The 
reproducible  [15] absence of blood pressure fall 
during nighttime is associated with an increased 
rate of adverse events, such as stroke  [16] , and 
with a greater degree of target organ damage, for 
example, left ventricular hypertrophy  [17] . Fur-
ther, independently from hypertension, other 
conditions may be associated with absence of 
dipping, for example, diabetes, obesity, auto-
nomic dysfunction, and menopause  [18 – 21] . 
 Introduction 
 & 
 Cushing ’ s disease is a rare endocrine disorder asso-
ciated with considerable morbidity and mortality 
due to cardiovascular or cerebrovascular events, 
such as stroke, myocardial infarction, chronic heart 
failure, and pulmonary edema  [1 – 4] . Mortality for 
patients cured of Cushing ’ s disease, initially as high 
as 50  %  [1] , now approaches that of the general 
population  [4 – 7] , but several features of hypercor-
tisolism, most notably hypertension, diabetes and 
obesity, may persist notwithstanding the normali-
zation of hypothalamo-pituitary-adrenal (HPA) 
function  [2,  8] . Indeed, patients with Cushing ’ s dis-
ease appear to maintain an increased risk proﬁ le 
for cardiovascular events even after removal of the 
pituitary tumor  [9] and in-depth evaluation of indi-
vidual contributors to cardiovascular risk is needed 
in order to target therapeutic interventions. 
 Hypertension features as one of the main con-
tributors to cardiovascular risk in terms both of 
absolute systolic and diastolic blood pressure 
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 Abstract 
 & 
 Hypertension is a major feature of Cushing ’ s 
disease, with the attendant increase in the rate 
of cardiovascular events. The circadian blood 
pressure proﬁ le also impacts cardiovascular risk 
and a few studies have shown that patients with 
Cushing ’ s syndrome do not present the expected 
nocturnal blood pressure decrease and, further, 
that this alteration persists in short-range dis-
ease remission. These studies were performed 
by conventional discontinuous ambulatory pres-
sure monitoring, a technique not devoid of limi-
tations. Aim of our study was the assessment of 
blood pressure and heart rate proﬁ le by beat-to-
beat noninvasive monitoring in twelve patients 
with active Cushing ’ s disease (9 women and 3 
men, age 33.3  ±  2.36 years) and the assessment of 
its possible changes at short- (  <  1 year) and long-
term (2 – 3 years) follow-up after curative sur-
gery. No nocturnal blood pressure dipping (i.e., 
decrease by 10  % of daytime values) was observed 
in 50  % of patients both during active hypercorti-
solism and within 1 year from surgery. Recovery 
of blood pressure dipping proﬁ le was detected 
at long-term follow-up in a minority of patients. 
Daytime heart rate was higher in patients with 
active Cushing ’ s disease and decreased over time 
after cure. In conclusion, patients with Cushing ’ s 
disease present absent nocturnal blood pressure 
dipping and abnormal heart rate values which do 
not resolve after short-term remission of hyper-
cortisolism and show only partial improvement 
in the long run. These ﬁ ndings identify additional 
cardiovascular risk factors for patients cured of 
Cushing ’ s disease. 
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 Past studies of circadian blood pressure proﬁ le in patients with 
Cushing ’ s syndrome, both endogenous and exogenous, revealed 
a high proportion of  “ nondippers ”  [22,  23] , thus pointing to ﬂ at-
tened circadian proﬁ le as an adjunctive cardiovascular risk fac-
tor. These studies, however, were performed using single, 
discontinuous noninvasive ambulatory blood pressure monitor-
ing which, although widely used for clinical purposes, is subject 
to considerable intra-individual variability and does not allow 
unequivocal classiﬁ cation of dipping status  [15,  24,  25] . 
 From the abovementioned, it appears that evaluation of 24-hour 
blood pressure proﬁ les in patients with Cushing ’ s disease by 
more reliable techniques is necessary to deﬁ nitively establish 
day-night blood pressure changes in these patients. Further, 
reassessment of circadian blood pressure proﬁ les after curative 
surgery may provide further information not only on the causal 
role of hypercortisolism in the altered nocturnal blood pressure 
fall but also on the contribution of persistent hemodynamic 
alterations to residual cardiovascular risk in patients cured of 
Cushing ’ s disease. The aim of our study was to precisely deﬁ ne 
circadian blood pressure and heart rate proﬁ le via computer-
assisted analysis of 24-hour noninvasive beat-by-beat ambula-
tory blood pressure recordings (Portapres device) in patients 
with Cushing ’ s disease before and after correction of hypercorti-
solism. This analysis integrates more than 100000 blood pres-
sure and heart rate values continuously recorded over the day 
and night and provides a detailed and reliable assessment of 24-
hour blood pressure and heart rate variations  [26] . 
 Patients and Methods 
 & 
 We studied 12 patients with Cushing ’ s disease (3 men, 9 women; 
mean age 33.3  ±  2.36 years, range 19 – 45 years). The diagnosis of 
Cushing ’ s disease had been established by standard diagnostic 
criteria  [27] and conﬁ rmed by pathology of specimens excised 
by transsphenoidal surgery. All patients were studied in the 
active phase of the disease and again within 1 year (median 5.4 
months) from surgical remission of hypercortisolism  [27] ; 7 
patients were restudied 1 – 3 years (median 15.8 months) after 
surgery. Five patients were hypertensives (142.0  ±  7.21 / 83.5  ±  4.97 
mmHg) and 3 additional patients were classiﬁ ed as having high 
normal blood pressure (135.6  ±  4.3 / 73.7  ±  1.81  mmHg) [>120 / 80; 
  <  140 / 90  mmHg]  [28] ( Table 1 ). Four patients were on antihyper-
tensive medication before surgery; antihypertensive treatment 
was continued in all patients for 1 year after surgery and for 
2 years at prolonged follow-up ( Table 1 ). Six patients tested 
within 1 year from surgery were on steroid replacement therapy 
while steroids had been tapered off in all patients retested after 
1 – 3 years. Three patients were obese (BMI 42.5 – 51.3  kg / m 2 ), 4 
overweight (BMI 26.1 – 28.3  kg / m 2 ), and the remaining 5 normal 
weight during the active phase of disease. Body weight fell in all 
patients after surgery, most markedly in the three obese patients 
(BMI at last follow-up 33.7 – 38.9  kg / m 2 ). 
 Endocrine evaluation 
 Twenty-four hour free cortisol (UFC) excretion was measured by 
radioimmunoassay of collected urine by extraction with dichlo-
romethane (Byk-Sangtec Diagnostica, Germany). Samples for 
plasma ACTH and serum cortisol were collected in the morning 
after an overnight fast and measured by immunometric assays 
(Liason, Nichols Institute Diagnostics, San Juan Capistrano USA). 
Normal ranges in our laboratory are 2 – 11  pmol / l (10 – 50  pg / ml) 
for ACTH, 138 – 690  nmol / l (5 – 25   g / dl) for 9.00  h serum cortisol, 
and 27.6 – 220.5  nmol / 24 h (10 – 80   g / 24  h) for UFC. 
 Plasma samples for estimation of plasma renin activity and 
aldosterone concentrations were collected after overnight rest-
ing (clinostatism) and again after two hours of upright position 
(orthostatism). Both hormones were assayed by radioimmu-
noassay (Technogenetics, Cassina D é Pecchi, Italy). Normal 
ranges for renin and aldosterone, in clino- and orthostatism, are 
0.2 – 2  ng / ml / h and 1.5 – 5  ng / ml / h, and 277 – 4160  nmol / l (10 –
 150  ng / l) and 830 – 8880  nmol / l (30 – 320  ng / l), respectively. 
Plasma samples for norepinephrine and epinephrine assays 
were collected after an overnight fast in nonstressed conditions, 
extracted with allumin and hormones assayed by HPLC. Normal 
ranges are 460 – 3000  nmol / l (78 – 521  ng / l) for norepinephrine 
and 55 – 1070  nmol / l (10 – 196  ng / l) for epinephrine. 
 Table 1  Patient characteristics and antihypertensive medication 
   Active phase  Within 1 year of surgery  Within 3 years of surgery 
 Pt  age /
 sex 
 Blood pressure 
status * 
 Medication  Blood pressure 
status * 
 Medication  Blood pressure 
status * 
 Medication 
 1  34 / F  normal   normal   normal  
 2  39 / F  grade 1 hypertension  quinalapril 20  mg 
hydrochlorthiazide 
12.5  mg 
 grade 1 hypertension  unchanged  grade 1 hypertension  unchanged 
 3  36 / F  normal   normal   normal  
 4  33 / F  high normal   normal   normal  
 5  45 / F  grade 1 hypertension  losartan 50  mg  grade 1 hypertension  unchanged  grade 1 hypertension  unchanged 
 6  45 / F  normal   normal   normal  
 7  22 / M  grade 1 hypertension  nifedipine 20  mg  grade 1 hypertension  lacidipine 4  mg 
atenolol 25  mg 
 grade 1 hypertension  atenolol 25  mg 
 8  27 / F  grade 1 hypertension  cilazapril 5  mg  grade 1 hypertension  cilazapril 5  mg 
amlodipine 5  mg 
 grade 1 hypertension  fosinopril 10  mg 
 9  38 / F  high normal   normal   normal  
 10  34 / M  grade 1 hypertension  no therapy  normal   normal  
 11  28 / F  normal   normal   normal  
 12  19 / M  high normal   normal   normal  
 * Blood pressure status deﬁ ned according to the 2003 Guidelines of the European Society of Cardiology [28] 
 Patients 1 – 5 were tested with Portapres at short-term follow-up only 
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 Portapres 
 Beat-to-beat ﬁ nger blood pressure was monitored noninvasively 
through a Portapres model 2 device over 24 hours based on the 
arterial volume clamp method  [26] . In brief, the device meas-
ures blood pressure through two small ﬁ nger cuffs wrapped 
around the middle and ring ﬁ ngers of the nondominant hand 
which are alternated every 30  minutes. The device includes a 
system capable of automatically correcting for changes in ﬁ nger 
pressure induced by hand displacements during daily life activi-
ties, by measuring the hydrostatic height difference between the 
instrumented ﬁ nger and the heart level. The height-corrected 
ﬁ nger arterial pressure and the hydrostatic height signal were 
stored together. Several papers have shown that use of Portapres 
technology, and in the more commonly employed stationary 
Finapres device based on the same blood pressure measuring 
approach, provides a reliable assessment of blood pressure vari-
ations over 24 hours, including beat-by-beat changes  [26,  29,  30] . 
Possible problems related to analysis of ﬁ nger blood pressure 
signal, known to be affected by physiological pulse wave distor-
tion and by the progressive reduction in mean arterial pressure 
from centre to periphery along the arterial tree, were taken into 
account by application of an  ad hoc digital ﬁ lter and by blood 
pressure correction algorithm  [31,  32] . The average discrepancy 
between the mean of three repeated arm cuff auscultatory read-
ings and the mean of 5-minute continuous ﬁ nger BP recordings 
was   <  5  mm Hg in all patients. Antihypertensive medications 
were interrupted 7 days prior to testing. 
 Patients were asked to observe the following standardized activi-
ties: 1) 60-minute walking in the morning; 2) 90-minute nap 
after lunch; 3) 30-minute cycling at 50  W in the afternoon; 4) 
sleep between 10 PM and 6 AM. All patients were examined as 
inpatients both before and after surgery and monitored by one 
investigator during portapres registration (A.M.). Patients were 
asked about their sleep pattern on the morning after and none 
referred signiﬁ cant disturbances in sleep. Informed consent to 
participate in the study was obtained from all patients. The study 
protocol was approved by our Institution ’ s Ethical Committee. 
 Recordings were analyzed by a specialized software obtaining 
24-hour, day (6:00 AM – 10:00 PM) and night (10:00 PM – 6:00 
AM) mean systolic and diastolic blood pressures and 24-hour, 
day and night mean heart rates. Day-night blood pressure ratios 
were calculated according to the formula: (mean day blood 
pressure / mean night blood pressure)   ×  100  [17] ; patients in 
whom nighttime values fell by at least 10  % of daytime values 
were classiﬁ ed  “ dippers ” while those in whom blood pressure 
did not were classiﬁ ed  “ nondippers ” . Heart rate values were 
classiﬁ ed in quartiles established by Verdecchia et al.  [33] and 
circadian heart rate rhythm became ﬂ attened with less than 10  % 
day-night heart rate decrease  [33] . 
 Statistical analysis 
 Comparisons of values recorded before and after surgery in the 
same patient were performed by Wilcoxon ’ s paired rank test and 
signiﬁ cance adjusted with Bonferroni ’ s correction for multiple 
comparisons. Ninety-ﬁ ve percent conﬁ dence intervals of the dif-
ferences were calculated in order to obtain estimates of the differ-
ence  [34] . Qualitative variables were compared by chi-squared 
test or Fisher ’ s exact test, as appropriate. Linear regression analy-
sis was performed to assess association between variables. Data 
are given as mean  ±  S.E.M. or percentage and 95  % conﬁ dence 
intervals  [34] . Statistical signiﬁ cance was accepted for p   <  0.05. 
 Results 
 & 
 Active disease 
 Average blood pressure and heart rate values in patients with 
Cushing ’ s disease are shown in  Table 2 . The physiological noc-
turnal blood pressure fall was lost in half of the patients with 
active Cushing ’ s disease. Representative examples of normal, 
hypertensive dipping and Cushing ’ s normotensive nondipping 
individuals are shown in     Fig. 1 ; mean 24-hour systolic blood 
pressure, diastolic blood pressure and heart rate proﬁ les in all 
patients with Cushing ’ s disease are shown in     Fig. 2 . Only 6 out 
of 12 patients qualiﬁ ed as  “ dippers ” (    Fig. 3 ). Mean 24-hour 
heart rate was in the highest quartile  [33] in 9 out of 12 subjects 
reﬂ ecting increased daytime heart rate values ( Table 2 ,     Fig. 2 ) 
while the nocturnal heart rate decrease was preserved (mean 
day-night decrease 26.1  ±  2.36  % ). 
 Not surprisingly, BMI was higher in nondippers compared with 
dippers (36.6  ±  4.66 vs. 24.7  ±  0.99  kg / m 2 , 95  % C.I. 16.7; 7.2  kg / m 2 , 
p   <  0.05), independent of day or night blood pressure as no cor-
relation between BMI and blood pressure was detected. Con-
versely, no clear changes in day-night blood pressure drop with 
 Table 2  Blood pressure and heart rate circadian proﬁ le obtained with Portapres in patients with Cushing’s disease before and after surgery 
  Active disease  Within 1 year of surgery  Within 3 years of surgery 
   Mean values  Mean Difference vs. 
active disease (95  % CI) 
 Mean values  Difference vs. active 
disease (95  % CI) 
 24  h mean values      
 systolic BP (mmHg)  130.2  ±  5.28  109.2  ±  5.35 *   −  19.7 (  −  36.6;   −  5.3)  109.2  ±  5.42 *   −  24.3 (  −  38.1;   −  3.9) 
 diastolic BP (mmHg)  75.4  ±  3.04  64.7  ±  3.45 *   −  10.5 (  −  20.2;   −  1.2)  64.9  ±  3.62 *   −  13.3 (  −  20.8;   −  0.2) 
 heart rate (beats / min)  84.9  ±  2.40  83.3  ±  3.60   −  1.6 (  −  10.5; 7.3)  75.9  ±  1.98   −  9.0 (  −  16.4;   −  1.6) 
 day mean values      
 systolic BP (mmHg)  133.2  ±  5.39  111.8  ±  5.63 *   −  19.7 (  −  37.6;   −  5.2)  113.2  ±  6.06 *   −  22.9 (  −  37.8;   −  2.1) 
 diastolic BP (mmHg)  77.2  ±  2.94  66.3  ±  3.55 *   −  10.6 (  −  20.41;   −  1.39)  67.4  ±  4.09 *   −  6.5 (  −  20.2;   −  0.6) 
 heart rate (beats / min)  90.2  ±  2.35  86.9  ±  3.68   −  3.2 (  −  12.1; 5.7)  79.5  ±  2.32 *   −  10.7 (  −  18.4;   −  3.2) 
 night mean values      
 systolic BP (mmHg)  119.6  ±  5.76  104.4  ±  5.81   −  11.4 (  −  31.9; 1.5)  100.5  ±  4.77 *   −  23.5 (  −  36.8;   −  1.3) 
 diastolic BP (mmHg)  68.9  ±  4.04  61.9  ±  4.45   −  4.7 (  −  19.2; 5.2)  59.4  ±  3.69 *   −  13.8 (  −  22.2;   −  2.3) 
 heart rate (beats / min)  66.8  ±  2.19  69.4  ±  4.61  3.9 (  −  5.7; 10.9)  67.1  ±  2.30  0.3 (  −  6.8; 7.4) 
 nondippers (  % patients)  50  % (21.7;   −  79.3  % )  §   50  % (21.7;   −  79.3  % )  0 (  −  40.0  % ; 40.0  % )  28  % (5;  −  61.3  % )  22.0 (  −  17.6  % ; 61.6  % ) 
 * p  <  0.05  vs. active disease;   §  95  % C.I. in parentheses 
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age were detected but this is probably due to the relatively 
young average age of our patients. No difference in day-night 
blood pressure fall was observed between the two genders 
(  −  14.9  ±  3.61 / – 9.6  ±  2.611 vs.   −  9.8  ±  5.2 /  −  4.5  ±  6.24  mmHg for 
females and males, respectively; 95 C.I.  – 23.5; 13.3  mmHg for 
systolic blood pressure,   −  17.7; 7.5  mmHg for diastolic blood 
pressure, NS). The duration of disease was longer in hyperten-
sive patients compared with normotensive patients although 
this difference did not reach statistical signiﬁ cance (7.1  ±  2.16 
years vs. 4.2  ±  1.25 years, respectively; 8.1;   −  2.3 years, NS). Fur-
ther stratiﬁ cation according to weight, gender or smoking failed 
to reveal signiﬁ cant differences in cardiovascular parameters. 
 Plasma renin activity increased modestly upon upright posture 
with resting values barely comprised in the normal range ( Table 3 ). 
Aldosterone in resting and upright posture as well as catecho-
lamines were comprised in the reference range for all subjects. 
No correlation was detected between hormonal levels and car-
diovascular parameters, as well as with BMI. 
 Postsurgical evaluation 
 A signiﬁ cant decrease in average systolic, diastolic, and mean 
blood pressure was observed within 1 year of surgery in all 
patients ( Table 2 ,     Fig. 2 ). On average, 24-hour systolic blood 
pressure fell by 19.7  ±  5.62  mmHg and diastolic blood pressure 
by 10.5  ±  4.29  mmHg (reaching 85.5 and 87.2  % of pretreatment 
values, respectively). Daytime blood pressure fell by 19.7  ±  5.51 / 
10.6  ±  4.08  mmHg (achieving 85.6 and 87.0  % of pretreatment 
 values for systolic and diastolic values, respectively) while the 
nighttime blood pressure descent amounted to 11.4  ±  6.20 / 4.7  ± 
5.81  mmHg, reaching 91.0 and 95.3  % of pretreatment values 
for systolic and diastolic values, respectively. The decrease in 
both daytime and nighttime blood pressure was not sufﬁ cient to 
reinstate the physiological blood pressure ﬂ uctuation between 
day and night, and the percentage of nondippers remained 
unchanged at 50  % . In detail, dipping status was recovered in 
3 previously nondipping patients and lost in 3 patients who 
qualiﬁ ed as dippers in the active phase (    Fig. 3 ). 
 A more pronounced decrease in nighttime blood pressure was 
observed at prolonged follow-up ( Table 2 ) with mean night val-
ues falling by 23.5  ±  5.39 / 13.8  ±  4.74  mmHg (reaching 82.4 and 
83.3  % of pretreatment; p  =  0.07 vs. 1 year follow-up). Twenty-
four hour and daytime blood pressures at prolonged follow-up 
were basically superimposable to earlier postsurgical measure-
ments (24-hour blood pressure decrease: 24.3  ±  5.41 / 13.3  ±  3.36 
mmHg; 82.6 and 83.8  % of pretreatment values for systolic and 
diastolic blood pressure, respectively; daytime blood pressure 
decrease: 22.9  ±  6.48 / 12.0  ±  3.97  mmHg; 84.1 and 85.7  % of pre-
treatment; NS vs. 1 year follow-up). On balance, this pattern 
allowed recovery of dipping proﬁ le in an additional nondipper 
patient thus lowering the percentage of nondippers at prolonged 
follow-up (28 vs. 50  % in the active phase, p  =  0.6 by Fisher ’ s 
exact test;  Table 2 ,     Fig. 3 ). 
 A progressive reduction in 24-hour heart rate could be observed 
throughout follow-up ( Table 2 ) although comparisons yielded 
marginal signiﬁ cance only at long-term evaluation (p  =  0.056, 
    Fig. 2 ). Overall, only 1 patient still fell in the highest heart rate 
quartile  [33] at long-term follow-up. Stratiﬁ cation according to 
day-night phase revealed a signiﬁ cant decrease in daytime heart 
rate (12.1  ±  4.41  b / min at long-term follow-up; achieving 87.8  % 
of pretreatment values,  Table 2 ) while nighttime values were on 
the whole unchanged during postsurgical observation (102.9  % 
of pretreatment values). Accordingly, the day-night heart rate 
difference was signiﬁ cantly smaller after surgery compared with 
pretreatment values (25.2  ±  3.65  b / min vs. 12.8  ±  2.35  b / min vs. 
12.5  ±  1.89  b / min at pretreatment, ﬁ rst and second postsurgical 
evaluation, respectively, p   <  0.01 vs. pretreatment for all com-
parisons) although still maintained within the expected 10  % 
day-night decrease (15.5  ±  2.26  % at last observation). 
 No signiﬁ cant changes in aldosterone and plasma renin activity 
in upright and recumbent position, and in epinephrine and 
norepinephrine concentrations were observed at short and 
long-term follow-up compared with values registered in the 
active phase ( Table 3 ). Obviously, cortisol and ACTH levels 
decreased signiﬁ cantly after surgery. No clear association 
between changes in hormonal, BMI and cardiovascular parame-
ters at follow-up could be observed by regression analysis. 
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 Fig. 1  Representative portapres recording of systolic and diastolic blood 
pressure (upper plot) and pulse interval (lower plot).  Panel A : normal 
subject;  Panel B : hypertensive patient with preserved day-night variation; 
 Panel C : normotensive patient with Cushing ’ s disease and absent 
nocturnal dipping. Blood pressure recording is depicted starting at 1:00 PM 
(13:00  h). 
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 Discussion 
 & 
 Cardiovascular risk is known to depend on several factors, 
including clinical, biochemical, inherited, and behavioral ele-
ments. In this context, primary importance has been ascribed to 
elevated blood pressure, as hypertension represents one of the 
most important determinants of cardiovascular event rate  [28] . 
Not only mean blood pressure levels but also blood pressure 
variations may contribute to cardiovascular risk. Indeed, blood 
pressure is characterized by a circadian pattern with higher lev-
els during the daytime followed by a decline during the night. 
Subjects presenting an appropriate decrease in nighttime blood 
pressure (i.e., greater than 10  % of daytime blood pressure) are 
classiﬁ ed as  “ dippers ” while those who do not are deﬁ ned  “ non-
dippers ”  [17] . Population studies have shown that the majority 
of hypertensive patients maintain a physiological variation pat-
tern between day and night while the 24-hour blood pressure 
proﬁ le appears ﬂ attened in approximately one third  [11,  14] . 
 “ Nondipper ” hypertensives present greater left ventricular mass, 
faster progression of microalbuminuria and renal damage, 
higher number of silent ischemic / hemorragic cerebrovascular 
brain lesions, increased vascular stiffness, higher rate of cardio-
vascular events, and even increased cardiovascular mortality 
rate  [12,  35 – 37] , especially in subjects with reproducible altera-
tions in the day-night blood pressure proﬁ le  [15] . Nondipping 
occurs more frequently among diabetic and obese patients 
 [18,  19] and dipping status may represent an independent risk 
factor for neuropathy, nephropathy, and vascular events in dia-
betic patients  [38,  39] . 
 Factors governing lack of night-time blood pressure dipping are 
as yet not fully understood, but inappropriate activation of the 
sympathetic nervous system  [40] , impaired natriuresis  [41] , and 
sleep apnea  [42] may play a role. In addition, physiological 
changes in behavior such as sleep, rest, and physical activity may 
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 Fig. 2  Mean 24-hour blood pressure and heart rate 
proﬁ les in patients with Cushing ’ s disease before and 
after surgery. Mean systolic (upper left) and diastolic 
(upper right) blood pressures hourly values recorded 
in the active phase (black line), at early postoperative 
follow-up (grey line) and late postoperative follow-
up (dotted black line) are shown. Slashed gray 
line indicates normal blood pressure reference 
levels:   <  135 / 85 for daytime hours,   <  115 / 75 for 
nighttime hours. Mean heart rate (below left) values 
follow the same legend. Reference data (  <  80 b / min 
for daytime hours,   <  70 b / min for nighttime hours) 
were taken from reference  [33] . Blood pressure and 
heart rate recordings are depicted starting at 8:00 
AM (8:00  h). 
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 Fig. 3  Day-night changes in individual patients 
with Cushing ’ s disease before and after surgery. 
Percent day-night systolic (left) and diastolic (right) 
blood pressure decrease in the active phase, at early 
postoperative follow-up and late postoperative 
follow-up. Dotted gray line indicates the expected 
10  % drop; grey circles indicate dippers, white circles 
indicate nondippers. 
 Table 3  Hormonal values in patients with Cushing’s disease before and after surgery 
  Active disease  1 year after surgery  1 – 3 years after surgery 
 plasma renin activity (ng / ml / h)    
 resting (range 0.2 – 2)  0.4  ±  0.06  1.0  ±  0.43  0.4  ±  0.15 
 upright (range 1.5 – 5)  1.4  ±  0.52  2.6  ±  0.82  1.6  ±  .036 
 plasma aldosterone (nmol / l)    
 resting (range 277 – 4160)  978.6  ±  150.91  1167.7  ±  313.61  1848.6  ±  419.22 
 upright (range 830 – 8880)  2403.2  ±  488.06  3420.7  ±  135.88  3895.1  ±  137.61 
 catecholamines (nmol / l)    
 norepinephrine (range 460 – 3000)  1035.4  ±  202.62  1486.0  ±  259.31  984.4  ±  118.70 
 epinephrine (range 55 – 1070)  102.6  ±  17.14  149.5  ±  16.42  125.5  ±  12.26 
 All comparisons are not signiﬁ cant 
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contribute to absence of dipping  [43] . Corticosteroids are known 
to inﬂ uence blood pressure per se and are believed to play a role 
also in nocturnal dipping according to the evidence accrued in 
patients treated with these compounds. In fact, blunted systolic 
and diastolic blood pressure nighttime decrease has been 
observed in patients treated with glucocorticoids at pharmaco-
logical dosages  [44] while replacement doses of steroids restore 
blood pressure rhythm in patients with Addison ’ s disease who 
lack normal 24-hour blood pressure proﬁ les  [45,  46] . 
 In view of the above, and including the prominent role of noc-
turnal hypertension in patients presenting features common in 
Cushing ’ s syndrome, such as obesity and diabetes, the evalua-
tion of circadian blood pressure proﬁ le in hypercortisolemic 
patients is of considerable interest. Initial observations on small 
groups of patients with Cushing ’ s syndrome reporting the ﬂ at-
tening of the circadian blood pressure proﬁ le  [22,  47 – 49] have 
recently been conﬁ rmed in a large series of patients with pitui-
tary or adrenal Cushing ’ s syndrome  [23] . This latter study evalu-
ated circadian blood pressure proﬁ le at the diagnosis and after 
brief postsurgical follow-up using discontinuous noninvasive 
ambulatory blood pressure monitoring and observed a signiﬁ -
cantly higher proportion of  “ nondippers ” among patients with 
Cushing ’ s syndrome than that recorded in essential hyperten-
sives. Blood pressure readings obtained from ambulatory blood 
pressure monitoring, however, may vary considerably in the 
same subject over time, and establishment of dipping status on 
the basis of a single monitoring has been questioned  [15,  24,  25] . 
Measurement of blood pressure at closer intervals than those 
employed with conventional ambulatory monitoring, that is, on 
a beat-by-beat basis instead of every 15 – 30  minutes, is now 
available through noninvasive devices, such as Portapres, and is 
likely to yield more reliable results  [26,  30] as it is based on more 
than 100000 values rather than on approximately 90 readings. 
Our results using this method provide unequivocal evidence for 
the high prevalence of  “ nondipping ” among patients with Cush-
ing ’ s disease, as the systolic and diastolic blood pressure decrease 
during the night fell short of the 10  % threshold in over half of 
our patients. Short-term reevaluation after remission of hyper-
cortisolism, that is, within 1 year from surgery, revealed that 
although average blood pressure fell consistently in all patients, 
the prevalence of nondippers remained high. In those patients 
evaluated after longer follow up (upto 3 years after surgery), a 
progressive recovery in nocturnal blood pressure dipping was 
observed in some individuals, leading to a slight amelioration in 
average dipping status. These ﬁ ndings indicate that mechanisms 
controlling nocturnal blood pressure dipping are severely 
affected by hypercortisolism and require a considerable period 
of time to normalize, if ever, after reestablishment of normal 
cortisol secretion. 
 A novel ﬁ nding relates to elevated heart rate, a condition which 
has recently been shown to adversely affect cardiovascular risk 
 [33,  50] . We observed that patients with Cushing ’ s disease often 
present increased 24-hour heart rates, due mainly to an increase 
in daytime heart rate. In contrast with blood pressure, increased 
heart rate values fell less dramatically after surgery and normal-
ized only at prolonged follow-up. Past studies in patients with 
Cushing ’ s syndrome had focused on the day-night heart rate 
decrease  [22,  47,  49] , which indeed is preserved in these patients, 
but did not report on absolute 24-hour and daytime heart rate 
values. The different behavior of diurnal and nocturnal heart 
rates may indicate an imbalance in neural cardiac reactivity 
involving sympathetic and parasympathetic activity during day-
time but not during nighttime and deserve to be further investi-
gated  [33,  50] . 
 Successful treatment of Cushing ’ s syndrome resolves around 
most signs and symptoms developed during the course of the 
disease  [2,  51,  52] but some features of hypercortisolism may 
persist even after curative surgery / radiotherapy, such as ele-
vated blood pressure values  [8,  53] , altered glucose metabolism 
and insulin resistance  [54,  55] , obesity  [56] and GH deﬁ ciency 
 [57] , all leading to increased cardiovascular risk proﬁ le in the 
long-term  [9] . The persistence of absence of nocturnal blood 
pressure dipping and increased 24-hour heart rates after remis-
sion of hypercortisolism over short term and, possibly, also long 
term, may contribute to persistent risk for cardiovascular events 
in patients cured from Cushing ’ s disease. Treatment for patients 
recovering from Cushing ’ s syndrome should therefore also be 
targeted to these alterations in blood pressure and heart rate 
proﬁ les  [50,  58] . 
 In conclusion, our data demonstrate that the majority of patients 
with active Cushing ’ s disease present impaired circadian blood 
pressure and heart rate proﬁ les. These alterations persist early 
after remission of hypercortisolism and appear to partially ame-
liorate only in the long-term. Thus, the absence of nocturnal 
blood pressure  “ dipping ” represents an additional cardiovascu-
lar risk factor that may contribute to excess cardiovascular mor-
bidity in the active phase of the disease and, possibly, also after 
remission of hypercortisolism. 
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